ContractWarrant Agreement • March 24th, 2022 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 24th, 2022 Company Industry JurisdictionTHIS WARRANT AND THE SHARES ISSUABLE HEREUNDER HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR THE SECURITIES LAWS OF ANY STATE AND MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE TRANSFERRED, EXCEPT AS SET FORTH IN SECTIONS 6.3 and 6.4 BELOW, UNLESS AND UNTIL REGISTERED UNDER SAID ACT AND LAWS OR, IN THE OPINION OF LEGAL COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE COMPANY, SUCH OFFER, SALE, PLEDGE OR OTHER TRANSFER IS EXEMPT FROM SUCH REGISTRATION.
SECURITY AGREEMENTSecurity Agreement • March 24th, 2022 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 24th, 2022 Company Industry JurisdictionTHIS SECURITY AGREEMENT (as amended, supplemented or otherwise modified from time to time, this “Agreement”), dated as of March 23, 2022, is made by and among ADMA BIOLOGICS, INC., a Delaware corporation (the “Borrower”), the Subsidiaries of the Borrower named in the signature pages hereto or having joined this Agreement pursuant to Section 23 (each a “Subsidiary Guarantor” and, together with the Borrower, each a “Grantor” and, collectively, the “Grantors”), and HAYFIN SERVICES LLP, as administrative agent for the Lenders referred to below (in such capacity, together with its successors and assigns, the “Agent”).
CREDIT AGREEMENT AND GUARANTY dated as of March 23, 2022 by and among ADMA BIOLOGICS, INC., as Borrower, THE LENDERS PARTY HERETO, and HAYFIN SERVICES LLP, as the Agent for the LendersCredit Agreement • March 24th, 2022 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 24th, 2022 Company Industry JurisdictionCREDIT AGREEMENT AND GUARANTY dated as of March 23, 2022 (as amended, supplemented or otherwise modified from time to time, this “Agreement”), by and among ADMA BIOLOGICS, INC., a Delaware corporation (the “Borrower”), the Subsidiaries of the Borrower from time to party hereto, as guarantors, the lenders from time to time party hereto (the “Lenders”) and HAYFIN SERVICES LLP, as Agent for the Lenders hereunder (in such capacity, together with its successors and assigns in such capacity, the “Agent”).